Published in Crit Care Med on May 01, 2008
Expectations and outcomes of prolonged mechanical ventilation. Crit Care Med (2009) 3.77
Variation in decisions to forgo life-sustaining therapies in US ICUs. Chest (2014) 2.69
Chronic critical illness. Am J Respir Crit Care Med (2010) 2.42
Death after percutaneous dilatational tracheostomy: a systematic review and analysis of risk factors. Crit Care (2013) 2.17
A multicenter mortality prediction model for patients receiving prolonged mechanical ventilation. Crit Care Med (2012) 1.92
Development and pilot testing of a decision aid for surrogates of patients with prolonged mechanical ventilation. Crit Care Med (2012) 1.76
Health care resource use and costs of two-year survivors of acute lung injury. An observational cohort study. Ann Am Thorac Soc (2015) 1.45
Development and validation of a printed information brochure for families of chronically critically ill patients. Crit Care Med (2012) 1.43
Inspiratory muscle strength training improves weaning outcome in failure to wean patients: a randomized trial. Crit Care (2011) 1.40
Effectiveness trial of an intensive communication structure for families of long-stay ICU patients. Chest (2010) 1.38
Prolonged acute mechanical ventilation and hospital bed utilization in 2020 in the United States: implications for budgets, plant and personnel planning. BMC Health Serv Res (2008) 1.23
Prolonged mechanical ventilation in critically ill patients: epidemiology, outcomes and modelling the potential cost consequences of establishing a regional weaning unit. Crit Care (2011) 1.19
Impact of chronic critical illness on the psychological outcomes of family members. AACN Adv Crit Care (2010) 1.11
Caregivers of the chronically critically ill after discharge from the intensive care unit: six months' experience. Am J Crit Care (2011) 1.01
Life expectancies and incidence rates of patients under prolonged mechanical ventilation: a population-based study during 1998 to 2007 in Taiwan. Crit Care (2011) 0.99
Anemia, transfusions and hospital outcomes among critically ill patients on prolonged acute mechanical ventilation: a retrospective cohort study. Crit Care (2008) 0.95
Mechanical ventilation, diaphragm weakness and weaning: a rehabilitation perspective. Respir Physiol Neurobiol (2013) 0.93
Decisional conflict and regret: consequences of surrogate decision making for the chronically critically ill. Appl Nurs Res (2011) 0.93
The reality of patients requiring prolonged mechanical ventilation: a multicenter study. Rev Bras Ter Intensiva (2015) 0.88
Use of mechanical ventilation by patients with and without dementia, 2001 through 2011. JAMA Intern Med (2014) 0.84
Informational coping style and depressive symptoms in family decision makers. Am J Crit Care (2010) 0.81
Strategies to combat chronic critical illness. Curr Opin Crit Care (2013) 0.80
Computational simulation indicates that moderately high-frequency ventilation can allow safe reduction of tidal volumes and airway pressures in ARDS patients. Intensive Care Med Exp (2015) 0.78
Use of ultrasound guidance to improve the safety of percutaneous dilatational tracheostomy: a literature review. Crit Care (2015) 0.76
A Comparative Data-Based Modeling Study on Respiratory CO2 Gas Exchange during Mechanical Ventilation. Front Bioeng Biotechnol (2016) 0.75
Between critical illness and hospital discharge: prolonged acute mechanical ventilation. Crit Care Med (2008) 0.75
Is tracheostomy a better choice than translaryngeal intubation for critically ill patients requiring mechanical ventilation for more than 14 days? A comparison of short-term outcomes. BMC Anesthesiol (2015) 0.75
Invasive Mechanical Ventilation in California Over 2000-2009: Implications for Emergency Medicine. West J Emerg Med (2015) 0.75
Can Tracheostomy Improve Outcome and Lower Resource Utilization for Patients with Prolonged Mechanical Ventilation? Chin Med J (Engl) (2015) 0.75
Chronic critical illness: are we saving patients or creating victims? Rev Bras Ter Intensiva (2017) 0.75
Year in review 2011: Critical Care--Resource management. Crit Care (2012) 0.75
Chronic critical illness: a growing legacy of successful advances in critical care*. Crit Care Med (2015) 0.75
The Prognostic Value of the Charlson's Comorbidity Index in Patients with Prolonged Acute Mechanical Ventilation: A Single Center Experience. Tuberc Respir Dis (Seoul) (2016) 0.75
The optimum timing to wean invasive ventilation for patients with AECOPD or COPD with pulmonary infection. Int J Chron Obstruct Pulmon Dis (2016) 0.75
The Utility of the Swine Model to Assess Biological Rhythms and Their Characteristics during Different Stages of Residence in a Simulated Intensive Care Unit: A Pilot Study. Chronobiol Int (2015) 0.75
Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. Clin Infect Dis (2012) 7.97
Critical care delivery in the United States: distribution of services and compliance with Leapfrog recommendations. Crit Care Med (2006) 4.85
Meta-analysis: outcomes in patients with suspected pulmonary embolism managed with computed tomographic pulmonary angiography. Ann Intern Med (2004) 3.97
Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005. Emerg Infect Dis (2008) 3.88
Etomidate is associated with mortality and adrenal insufficiency in sepsis: a meta-analysis*. Crit Care Med (2012) 3.86
Telavancin versus vancomycin for hospital-acquired pneumonia due to gram-positive pathogens. Clin Infect Dis (2011) 3.20
Blood transfusion and nosocomial infection: another brick in the wall. Crit Care Med (2006) 3.00
Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest (2006) 2.73
Longitudinal changes in procalcitonin in a heterogeneous group of critically ill patients. Crit Care Med (2012) 2.65
Ethical assessment of industry-sponsored clinical trials: a case analysis. Chest (2002) 2.27
Comparison of platelet transfusion as fresh whole blood versus apheresis platelets for massively transfused combat trauma patients (CME). Transfusion (2010) 2.24
Outcomes and safety of surgical lung biopsy for interstitial lung disease. Chest (2005) 2.20
Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure. Crit Care Med (2005) 2.12
Factors associated with acute lung injury in combat casualties receiving massive blood transfusions: a retrospective analysis. J Crit Care (2012) 2.09
Association between a silver-coated endotracheal tube and reduced mortality in patients with ventilator-associated pneumonia. Chest (2009) 2.09
Epidemiology, microbiology and outcomes of healthcare-associated and community-acquired bacteremia: a multicenter cohort study. J Infect (2010) 1.83
Resistant pathogens in nonnosocomial pneumonia and respiratory failure: is it time to refine the definition of health-care-associated pneumonia? Chest (2010) 1.81
A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. Intensive Care Med (2013) 1.74
Using the number needed to treat to assess appropriate antimicrobial therapy as a determinant of outcome in severe sepsis and septic shock. Crit Care Med (2014) 1.61
Accuracy of previous estimates for adult prolonged acute mechanical ventilation volume in 2020: update using 2000-2008 data. Crit Care Med (2012) 1.57
Prolonged acute mechanical ventilation, hospital resource utilization, and mortality in the United States. Crit Care Med (2008) 1.50
Interferon gamma-1b as therapy for idiopathic pulmonary fibrosis. An intrapatient analysis. Respiration (2004) 1.48
Antimicrobial therapy escalation and hospital mortality among patients with health-care-associated pneumonia: a single-center experience. Chest (2008) 1.47
Epidemiology and outcomes of clostridium difficile-associated disease among patients on prolonged acute mechanical ventilation. Chest (2009) 1.47
Secular trends in gram-negative resistance among urinary tract infection hospitalizations in the United States, 2000-2009. Infect Control Hosp Epidemiol (2013) 1.45
Activation of host wound responses in breast cancer microenvironment. Clin Cancer Res (2009) 1.45
Unnecessary use of placebo controls: the case of asthma clinical trials. Arch Intern Med (2002) 1.44
Potential limitations of clinical criteria for the diagnosis of idiopathic pulmonary fibrosis/cryptogenic fibrosing alveolitis. Respiration (2004) 1.44
The Role for Optical Density in Heparin-Induced Thrombocytopenia: A Cohort Study. Chest (2015) 1.43
Secular trends in candidemia-related hospitalization in the United States, 2000-2005. Infect Control Hosp Epidemiol (2008) 1.42
Should sedation be standardized in the intensive care unit? Crit Care Med (2008) 1.37
Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study. BMC Infect Dis (2010) 1.29
Perceived barriers to the use of sedation protocols and daily sedation interruption: a multidisciplinary survey. J Crit Care (2008) 1.27
Hospital resource utilization and costs of inappropriate treatment of candidemia. Pharmacotherapy (2010) 1.25
FDA guidance for ABSSSI trials: implications for conducting and interpreting clinical trials. Clin Infect Dis (2014) 1.25
The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis. Respir Med (2006) 1.25
Epidemiology, clinical and economic outcomes of admission hyponatremia among hospitalized patients. Curr Med Res Opin (2008) 1.23
Prolonged acute mechanical ventilation and hospital bed utilization in 2020 in the United States: implications for budgets, plant and personnel planning. BMC Health Serv Res (2008) 1.23
Appraising contemporary strategies to combat multidrug resistant gram-negative bacterial infections--proceedings and data from the Gram-Negative Resistance Summit. Clin Infect Dis (2011) 1.22
Ventilator-associated pneumonia: the clinical pulmonary infection score as a surrogate for diagnostics and outcome. Clin Infect Dis (2010) 1.21
Sarcoidosis involving the musculoskeletal system. Semin Respir Crit Care Med (2002) 1.20
Increase in Clostridium difficile-related hospitalizations among infants in the United States, 2000-2005. Pediatr Infect Dis J (2008) 1.20
Red blood cell transfusions and the risk of acute respiratory distress syndrome among the critically ill: a cohort study. Crit Care (2007) 1.14
Growth and geographic variation in hospitalizations with resistant infections, United States, 2000-2005. Emerg Infect Dis (2008) 1.10
Anidulafungin compared with fluconazole in severely ill patients with candidemia and other forms of invasive candidiasis: support for the 2009 IDSA treatment guidelines for candidiasis. Crit Care (2011) 1.09
Antimicrobial stewardship: shepherding precious resources. Am J Health Syst Pharm (2009) 1.08
An evaluation of the impact of apheresis platelets used in the setting of massively transfused trauma patients. J Trauma (2009) 1.08
Mitigating VTE in soldiers from Operation Iraqi Freedom and Operation Enduring Freedom. Chest (2014) 1.07
Hyponatremia and hospital outcomes among patients with pneumonia: a retrospective cohort study. BMC Pulm Med (2008) 1.05
Development and validation of a mortality risk-adjustment model for patients hospitalized for exacerbations of chronic obstructive pulmonary disease. Med Care (2013) 1.03
A risk score for identifying methicillin-resistant Staphylococcus aureus in patients presenting to the hospital with pneumonia. BMC Infect Dis (2013) 1.03
Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients. Breast Cancer Res (2012) 1.03
Clostridium difficile-associated disease and mortality among the elderly critically ill. Crit Care Med (2009) 1.01
Mortality and need for mechanical ventilation in acute exacerbations of chronic obstructive pulmonary disease: development and validation of a simple risk score. Arch Intern Med (2009) 1.01
Development and validation of a bedside risk score for MRSA among patients hospitalized with complicated skin and skin structure infections. BMC Infect Dis (2012) 1.00
Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review. BMC Pulm Med (2010) 1.00
Hospitalizations with healthcare-associated complicated skin and skin structure infections: impact of inappropriate empiric therapy on outcomes. J Hosp Med (2010) 0.99
Augmented renal clearance in septic and traumatized patients with normal plasma creatinine concentrations: identifying at-risk patients. Crit Care (2013) 0.99
Venous thromboembolic disease in the intensive care unit. Semin Respir Crit Care Med (2010) 0.98
Health care-associated infection (HAI): a critical appraisal of the emerging threat-proceedings of the HAI Summit. Clin Infect Dis (2008) 0.97
Cost-effectiveness of micafungin as an alternative to fluconazole empiric treatment of suspected ICU-acquired candidemia among patients with sepsis: a model simulation. Crit Care (2009) 0.97
Bacteremia in Staphylococcus aureus pneumonia: outcomes and epidemiology. J Crit Care (2010) 0.96
The protein C pathway: implications for the design of the RESPOND study. Crit Care (2007) 0.96
Epidemiology and outcomes of hospitalizations with complicated skin and skin-structure infections: implications of healthcare-associated infection risk factors. Infect Control Hosp Epidemiol (2009) 0.96
The adequacy of timely empiric antibiotic therapy for ventilator-associated pneumonia: an important determinant of outcome. J Crit Care (2011) 0.96
Anemia, transfusions and hospital outcomes among critically ill patients on prolonged acute mechanical ventilation: a retrospective cohort study. Crit Care (2008) 0.95
Implementing quality improvements in the intensive care unit: ventilator bundle as an example. Crit Care Med (2009) 0.95
The value of pretest probability and modified clinical pulmonary infection score to diagnose ventilator-associated pneumonia. J Crit Care (2008) 0.93
Fungal infections in the ICU. Infect Dis Clin North Am (2009) 0.92
Health care-associated pneumonia: identification and initial management in the ED. Am J Emerg Med (2008) 0.92
Economic aspects of preventing health care-associated infections in the intensive care unit. Crit Care Clin (2012) 0.91
Prevention of venous thromboembolism in neurosurgery: a metaanalysis. Chest (2008) 0.91
Economics at the end of life: hospital and ICU perspectives. Semin Respir Crit Care Med (2012) 0.91
Predictors for daily interruption of sedation therapy by nurses: a prospective, multicenter study. J Crit Care (2010) 0.91
Anemia, costs and mortality in chronic obstructive pulmonary disease. Cost Eff Resour Alloc (2006) 0.88
Twice vs three times daily heparin dosing for thromboembolism prophylaxis in the general medical population: A metaanalysis. Chest (2007) 0.87
Clinical and economic outcomes in patients with community-acquired Staphylococcus aureus pneumonia. J Hosp Med (2010) 0.87
Predictors of hospital mortality among septic ICU patients with Acinetobacter spp. bacteremia: a cohort study. BMC Infect Dis (2014) 0.86
Prolonged acute mechanical ventilation: implications for hospital benchmarking. Chest (2008) 0.86
Discordance between general and pulmonary pathologists in the diagnosis of interstitial lung disease. Respir Med (2005) 0.85
Healthcare-associated pneumonia: the state of evidence to date. Curr Opin Pulm Med (2011) 0.85
Linezolid does not increase the risk of thrombocytopenia in patients with nosocomial pneumonia: comparative analysis of linezolid and vancomycin use. Clin Infect Dis (2003) 0.85
Ventilator-associated pneumonia as a model for approaching cost-effectiveness and infection prevention in the ICU. Curr Opin Infect Dis (2011) 0.84
Update in ventilator-associated pneumonia. Curr Opin Anaesthesiol (2006) 0.84
Health care-associated candidemia--a distinct entity? J Hosp Med (2010) 0.84
Application of a population-based severity scoring system to individual patients results in frequent misclassification. Crit Care (2005) 0.84
Hospital days, hospitalization costs, and inpatient mortality among patients with mucormycosis: a retrospective analysis of US hospital discharge data. BMC Infect Dis (2014) 0.83
Telavancin for hospital-acquired pneumonia: clinical response and 28-day survival. Antimicrob Agents Chemother (2014) 0.83
Analyzing the short-term effect of placebo therapy in pulmonary arterial hypertension: potential implications for the design of future clinical trials. Chest (2007) 0.83
Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome. BMC Infect Dis (2011) 0.82
Rational dosing of antimicrobial agents: pharmacokinetic and pharmacodynamic strategies. Am J Health Syst Pharm (2009) 0.82
Effect of a restrictive transfusion strategy on transfusion-attributable severe acute complications and costs in the US ICUs: a model simulation. BMC Health Serv Res (2007) 0.82
Impact of prior probabilities of MRSA as an infectious agent on the accuracy of the emerging molecular diagnostic tests: a model simulation. BMJ Open (2012) 0.82
Transforming growth factor-β1 rise in pleural fluid after tunneled pleural catheter placement: pilot study. J Bronchology Interv Pulmonol (2013) 0.82
Fludarabine-related pulmonary toxicity: a distinct clinical entity in chronic lymphoproliferative syndromes. Chest (2002) 0.81
Preventing clostridium difficile infection in the intensive care unit. Crit Care Clin (2013) 0.81
Epidemiology of healthcare-associated pneumonia (HCAP). Semin Respir Crit Care Med (2009) 0.81